Menu Toggler

Alimera Sciences Inc

Most Recent

Company & Industry Overviews
Regeneron Pharmaceuticals and Its Financial Performance
Regeneron Pharmaceuticals (REGN) generated total revenues of $5.8 billion in fiscal 2017 compared with $4.8 billion in fiscal 2016.

By Kenneth SmithFeb. 19 2018, Published 7:17 a.m. ET
Company & Industry Overviews
A Look at Regeneron Pharmaceuticals’ Product Pipeline
Regeneron Pharmaceuticals (REGN) currently has 15 products in clinical development.

By Kenneth SmithFeb. 19 2018, Published 5:46 a.m. ET

ABOUT Market Realist
About Us
Privacy Policy
Terms of Use
DMCA

CONNECT with Market Realist

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.

Alimera Sciences Inc

Regeneron Pharmaceuticals and Its Financial Performance

A Look at Regeneron Pharmaceuticals’ Product Pipeline